Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Daniel Orringer

Neurological Surgery Ann Arbor, MI Medical Doctor

NPI 1124141296 CMS profile 481003

1500 E Medical Center Dr, 2Nd Floor Taubman Center Recp G, Ann Arbor, MI 48109

Open in the dashboard

General payments

$499,697

71 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Daniel Orringer of Ann Arbor, MI is reported in the CMS Open Payments database as having received $499,697 across 71 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $19,213 13
2023 General $46,743 25
2022 General $80,641 18
2021 General $145,700 3
2020 General $112,205 2
2019 General $95,195 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Orringer
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Daniel Orringer were reported at $0. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Daniel Orringer Neurological Surgery median Middle half National median
2019 $95,195 $582 $138–$3,006 $163
2020 $112,205 $294 $76–$2,174 $114
2021 $145,700 $387 $105–$2,432 $132
2022 $80,641 $542 $139–$2,989 $149
2023 $46,743 $534 $145–$2,697 $160
2024 $19,213 $574 $155–$3,046 $164
2025 $0 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. NX Development Corp. $385,207 6 payments
  2. Stryker Corporation $52,476 40 payments
  3. Servier Pharmaceuticals LLC $33,622 20 payments
  4. Medexus Pharma, Inc. $28,270 4 payments
  5. Integra LifeSciences Corporation $123 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $492,715 31 payments
  2. Travel and Lodging $5,976 24 payments
  3. Food and Beverage $1,006 16 payments
Products named General payments · program years 2019–2024
  1. Gleolan Prescription $298,061 4 payments
  2. Gleolan Prescription $79,496 1 payment
  3. CORE $27,760 9 payments
  4. Gleolan Neurological Surgery $20,020 3 payments
  5. NEW PRODUCT DEVELOPMENT $10,375 2 payments
  6. Gleolan Neurological Surgery $8,250 1 payment
  7. Gleolan Prescription $7,650 1 payment
  8. NAV - CRANIALMASK $3,150 3 payments
  9. SPETZLER-MALIS $1,600 2 payments
  10. SONOPET IQ $1,512 3 payments
  11. Other $3,140 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$75,896

Medicare's payments for the services billed

Medicare patients

50

Average age 74

Services billed

100

27 women, 23 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 60%
Ischemic heart disease 42%
Cancer 36%
Osteoporosis 36%
Depression 28%
Chronic kidney disease 24%
Diabetes 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

71 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record